Model Integration and Configuration for Antibody-Drug

Data Characteristics for this Category

Antibody-Drug Conjugate (ADC) data primarily originates from clinical trial reports, patent literature, drug monographs, biomedical journal articles, and specialized databases such as DrugBank, ClinicalTrials.gov, and PubChem. This data updates frequently, especially during new drug development and clinical trial phases. Document structures typically include target information, antibody sequences, linker structures, payload molecule types, conjugation methods, pharmacokinetic (PK) data, pharmacodynamic (PD) data, toxicity data, and clinical efficacy data. Fields and units are highly specialized. For example, antibody concentration may use µg/mL, drug dosage mg/kg, tumor inhibition rate a percentage, and linker length atomic count or nanometers. Precise identification and processing of these are essential.

Constraints Imposed by These Characteristics on Model Integration and Configuration

The highly specialized and structured nature of ADC drug data imposes specific requirements on model integration and configuration. First, the data contains numerous chemical structures, protein sequences, and complex biomedical terminology. This requires the model to process such multimodal information or to effectively convert it into text during preprocessing. Second, data formats vary across sources. Clinical trial reports are often PDFs or HTML, while patent documents have their own specific formats. This demands that the knowledge base's document parser flexibly adapt to multiple input types and accurately extract key fields. Furthermore, the high frequency of data updates means the knowledge base must support incremental updates and version management to ensure the timeliness and accuracy of consultation results. Finally, the specialized units and numerical ranges involved require the model to correctly understand and perform numerical comparisons and calculations during inference, preventing erroneous judgments due to unit confusion.

Configuration Guidelines

Configuration Item	Recommended Value	Rationale
`Chunk size` (Chunk Length)	`500–800 characters`	ADC data contains extensive continuous experimental results and descriptions. Chunks that are too short may lead to loss of context, while chunks that are too long introduce noise.
`Recall count` (Recall Count)	`8–12 entries`	Ensures coverage of multiple dimensions of ADC drugs, such as targets, structures, efficacy, and toxicity, preventing omission of critical details.
`Similarity threshold` (Similarity Threshold)	`0.75–0.85`	ADC concepts are highly specialized. A higher similarity is needed to ensure recalled documents are highly relevant to the user query, reducing false recalls.
`maxContext`	`3000–4000 tokens`	Complex descriptions, experimental data, and clinical results of ADC drugs require a sufficient context window for inference.
`PARSE_FILE_TIMEOUT_SECONDS`	`300 seconds`	Processing ADC-related PDFs or patent files containing numerous charts, complex tables, and long texts requires longer parsing times.
`Rerank result count` (Reranked Return Count)	`top 5 entries`	After recalling multiple entries, reranking selects the most relevant ones, improving the precision of the model's answers.

Three Common Mistakes

The knowledge base vector model switches but remains stuck for an extended period, with no progress and no rollback option. This occurs when an anomaly arises during new model loading or data re-indexing, causing background tasks to freeze.
Model inference answers are significantly shorter, failing to present comprehensive information about ADC drugs. This usually happens when the max_tokens parameter is set too low, limiting the completeness of the model's output.
For queries about the same ADC drug, the private knowledge base sometimes provides answers that conflict with the base model. This indicates a conflict between the knowledge base data and the base model's pre-trained knowledge, and the RAG recall strategy fails to effectively balance the weight of both.

How to Confirm Proper Configuration

Upload a PDF document containing ADC drug structures and PK/PD data. Check if the knowledge base chunking is reasonable and if key information is correctly extracted.
For a specific ADC drug, ask about its target, linker type, and main side effects. Compare the model's answer with the original document content to assess information accuracy and completeness.
Simulate user inquiries by asking questions involving numbers and units (e.g., "What is the MDR value of ADC drug X?"). Check if the model correctly understands and provides numerical answers with units.
In the model inference logs, review the context field to confirm that the recalled knowledge snippets cover the query keywords and that the content is highly relevant.

Note: The values provided are common starting points. Always measure against your own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.